| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.2M | -77.4% |
| SG&A Expense | $5.8M | +41.4% |
| Operating Income | -$6.9M | +25.2% |
| Net Income | -$7.0M | +24.5% |
| EPS (Basic) | -$0.69 | +51.4% |
| EPS (Diluted) | -$0.69 | +51.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | +2.1% |
| Current Assets | $4.2M | -48.9% |
| Total Assets | $4.2M | -50.2% |
| Current Liabilities | $1.8M | -26.0% |
| Total Liabilities | $1.8M | -28.1% |
| Stockholders' Equity | $2.3M | -59.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.1M | +14.2% |
| Investing Cash Flow | $3.8M | +198.4% |
| Financing Cash Flow | $3.4M | -78.2% |